NCT03635333

Brief Summary

This study looks at the effects of flavors when administered with nicotine in e-cigarettes in younger and older adult cigarette smokers.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
130

participants targeted

Target at P75+ for phase_1

Timeline
Completed

Started May 2019

Longer than P75 for phase_1

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 13, 2018

Completed
4 days until next milestone

First Posted

Study publicly available on registry

August 17, 2018

Completed
9 months until next milestone

Study Start

First participant enrolled

May 14, 2019

Completed
4.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 12, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 12, 2023

Completed
2.4 years until next milestone

Results Posted

Study results publicly available

December 19, 2025

Completed
Last Updated

December 19, 2025

Status Verified

December 1, 2025

Enrollment Period

4.2 years

First QC Date

August 13, 2018

Results QC Date

July 8, 2024

Last Update Submit

December 16, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change Score in Liking/Wanting of E-cigarette

    The Labeled Hedonic Scale (LHS; Lim et al., 2009) will be used to ask about liking and wanting of the e-cigarette (one item VAS scale \[range -100 to 100\] with ratings from most disliked sensation imaginable to most liked sensation imaginable with higher values indicating greater liking)

    Baseline (+10 minutes) to end of lab session (+40 minutes)

Study Arms (8)

Low nicotine, tobacco

EXPERIMENTAL

6 mg nicotine combined with tobacco flavored e-juice

Drug: NicotineDrug: Flavor

Low nicotine, menthol

EXPERIMENTAL

6 mg nicotine combined with menthol flavored e-juice

Drug: NicotineDrug: Flavor

Low nicotine,cherry

EXPERIMENTAL

6 mg nicotine combined with cherry flavored e-juice

Drug: NicotineDrug: Flavor

High nicotine, tobacco

EXPERIMENTAL

18 mg nicotine combined with tobacco flavored e-juice

Drug: NicotineDrug: Flavor

High nicotine, menthol

EXPERIMENTAL

18 mg nicotine combined with menthol flavored e-juice

Drug: NicotineDrug: Flavor

High Nicotine, cherry

EXPERIMENTAL

18 mg nicotine combined with cherry flavored e-juice

Drug: NicotineDrug: Flavor

Low Nicotine, Vanilla

EXPERIMENTAL

6 mg nicotine combined with vanilla flavored e-juice

Drug: NicotineDrug: Flavor

High Nicotine, Vanilla

EXPERIMENTAL

18 mg nicotine combined with vanilla flavored e-juice

Drug: NicotineDrug: Flavor

Interventions

Nicotine level (6 or 18 mg)

High Nicotine, VanillaHigh Nicotine, cherryHigh nicotine, mentholHigh nicotine, tobaccoLow Nicotine, VanillaLow nicotine, mentholLow nicotine, tobaccoLow nicotine,cherry
FlavorDRUG

Flavor of e-juice (tobacco, menthol, cherry, vanilla)

High Nicotine, VanillaHigh Nicotine, cherryHigh nicotine, mentholHigh nicotine, tobaccoLow Nicotine, VanillaLow nicotine, mentholLow nicotine, tobaccoLow nicotine,cherry

Eligibility Criteria

Age21 Years - 50 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Ages 21-34 years or 35 -50 years
  • Able to read and write
  • Smoking \>/= 1 cigarettes or cigars/day
  • Willing to abstain from regular smoking for 2 weeks and use only e-cigarettes
  • Not seeking treatment to stop smoking

You may not qualify if:

  • Daily use of other drugs including prescribed psychoactive drugs
  • Any significant current medical or psychiatric condition
  • Known hypersensitivity to propylene glycol
  • Pregnant or lactating females

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CMHC, Substance Abuse Center

New Haven, Connecticut, 06519, United States

Location

MeSH Terms

Conditions

Tobacco Use Disorder

Interventions

NicotineFlavoring Agents

Condition Hierarchy (Ancestors)

Substance-Related DisordersChemically-Induced DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Solanaceous AlkaloidsAlkaloidsHeterocyclic CompoundsPyridinesHeterocyclic Compounds, 1-RingPharmaceutic AidsPharmaceutical PreparationsFood AdditivesFood IngredientsSpecialty Uses of ChemicalsChemical Actions and UsesFoodDiet, Food, and NutritionPhysiological PhenomenaFood and Beverages

Results Point of Contact

Title
Danielle Davis
Organization
Yale University School of Medicine

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 13, 2018

First Posted

August 17, 2018

Study Start

May 14, 2019

Primary Completion

July 12, 2023

Study Completion

July 12, 2023

Last Updated

December 19, 2025

Results First Posted

December 19, 2025

Record last verified: 2025-12

Locations